Blood biomarkers and development of Atrial Fibrillation within 1 year, in frail older patients. Outcomes of the Dutch-GERAF study.

Back

ESC2025 Premium Access

Blood biomarkers and development of Atrial Fibrillation within 1 year, in frail older patients. Outcomes of the Dutch-GERAF study.

Session: Role of biomarkers in atrial fibrillation

Topic: Prevalence and Incidence of Atrial Fibrillation

Speaker: Mrs J. Spruit (Alkmaar, NL)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Mrs Jocelyn Spruit

Noordwest Hospital Group, Alkmaar (Netherlands (The))

0 follower

7 more presentations in this session

Assessment of 352 plasma biomarkers for predicting ischaemic stroke risk in atrial fibrillation patients without anticoagulation - A proteomic profiling study

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)

Selecting patients for targeted therapy with early rhythm control using BMP10 blood biomarker levels

Speaker: Mr C. Al-Taie (Hamburg, DE)

Identification of a lactylation-related gene signature as the novel biomarkers for early diagnosis of atrial fibrillation

Speaker: Doctor X. Long (Changsha, CN)

NT-proBNP may be used as a risk factor of stroke after the elimination of atrial fibrillation by catheter ablation

Speaker: Doctor S. Kudo (Amagasaki, JP)

Inflammatory biomarkers in symptomatic atrial fibrillation: a case-control study

Speaker: Doctor A. Jackson (Orebro, SE)

Access the full session

Role of biomarkers in atrial fibrillation

Speakers: Mrs J. Spruit, Associate Professor Z. Hijazi, Mr C. Al-Taie, Doctor X. Long, Doctor S. Kudo...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources